key: cord-0866664-i9fn8gd1
authors: Kleiboeker, Steven; Cowden, Scott; Grantham, James; Nutt, Jamie; Tyler, Aaron; Berg, Amy; Altrich, Michelle
title: SARS-CoV-2 Viral load Assessment in Respiratory Samples
date: 2020-05-19
journal: J Clin Virol
DOI: 10.1016/j.jcv.2020.104439
sha: 6abcbae5b4f9bb1ab627d5998f5ee8ca8fc995da
doc_id: 866664
cord_uid: i9fn8gd1

Real-time reverse transcriptase polymerase chain reaction (rRTPCR) has been the main method for diagnosis of SARS-CoV-2 infection in the early stages of the COVID-19 pandemic. De-identified results from upper and lower respiratory samples submitted to a reference laboratory demonstrated a positivity rate of 14.9% (4,428 of 29,713 samples tested). Distribution of results by birth year cohort and specimen type suggested general consistency in mean, median and peak values but higher positivity rates in individuals born from 1964 to 1974. Female patients had a significantly lower positivity rate (P < 0.0001), although similar load mean and median values, compared to males. Overall, 15.3% (676 of 4,428 positive results) of positive results had viral loads greater than 8 log10 copies/mL, with occasional samples exceeding 10 log10 copies/mL. These results support quantitative assessment of SARS-CoV-2 viral load in patient testing and efforts to control viral transmission

In the early stages of the COVID-19 pandemic, molecular testing by real-time reverse transcriptase polymerase chain reaction (rRT-PCR) has been the main method for diagnosis of SARS-CoV-2 infection in symptomatic patients (Corman et al., 2020) . Qualitative assays have primarily been used for this purpose.

Our reference laboratory developed and validated an assay that targets two regions of the N protein gene using standard rRT-PCR methods. Validation of upper and lower respiratory samples was focused on providing qualitative results. Positivity was defined as a cycle threshold (C T ) value < 38.0. This cutoff was derived from the mean C T value at the limit of detection plus approx. two standard deviations. Sensitivity of the assay, expressed as limit of detection, is 73 copies/mL. Although the intended use of the assay is to report qualitative results, linearity and dynamic range were assessed and demonstrated from 2.77 to 8.77 log 10 copies/mL (slope = -3.32, y-intercept = 41.2, R 2 = 0.9998), with C T values from 31.56 to 12.05 in the linear range of the assay. During review of laboratory results, we occasionally observed very low C T values (i.e. <10) from patient samples, suggesting extremely high concentrations of SARS-CoV-2 in respiratory specimens. This report characterizes the viral load of all positive samples in an unbiased reference laboratory caseload from the United States.

Using 29,713 de-identified rRT-PCR results, we described the viral load of respiratory samples tested during the first weeks of the COVID-19 pandemic in the United States. Overall 14.9% (4,428) of samples tested were positive for SARS-CoV-2. The distribution of positive samples by log 10 copies/mL and C T values is shown in Figure 1 . The overall viral load range of positive samples was 0.91 to 10.42 log 10 copies/mL (C T 6.16 -37.92) with a mean of 5.85 log 10 copies/mL and median of 6.05 log 10 copies/mL. Samples with greater than 8 log 10 copies/mL represented 15.3% (676 of 4,428) of results reported as positive. Samples with less than 3 log 10 copies/mL represented 9.89% (438 of 4,428) of results reported as positive. Table 1 . Patients born from 1955 to 1994 had both the highest number and percentage of positive results, with peak values in patients born from 1960 to 1974. Mean and median viral load values did not vary markedly based on birth cohort, although it was noted that the highest maximum values (>10 log 10 copies/mL) were in patients born from 1995 to 2009. In Table 2 , viral load results are shown by specimen type and patient gender. A majority of samples received (69.3% or 20,603 of 29,713) did not have the specific specimen type identified. When specimen type was identified, NP swabs were the majority of samples tested (84.3% or 7,682 of 9,110).

Although more females were tested, the percentage of samples tested which were positive was significantly lower (Chi square test, P < 0.0001) compared to males while no significant differences were observed in viral load mean or median values.

at high viral load levels in individual patients or small groups of patients. While some studies only report C T values, which may vary between methods, these results provide a reasonable approximation of viral load. Lack of a common standard makes comparison of calculated viral load values between studies an approximation as well. A study of 82 SARS-CoV-2 infected patients showed viral loads of 4 to 8 log 10 copies/mL in throat swabs and sputum from -1 to 15 days post-onset of clinical symptoms with occasional sputum samples having 10 to 11 log 10 copies/mL (Pan et al., 2020) . A second study of 17 symptomatic patients reported C T values as low as 13 in both throat and nasal swabs of one patient, with a majority samples having C T values >20 in the early clinical period (Zou et al., 2020) . Wang et al. (2020) reported C T values > 17 in similarly collected specimens. Viral load kinetics have also been studied with peak reported values of approx. 8 log 10 copies/mL (Kim et al., 2020) and 9 log 10 copies/mL (Wölfel et al., 2020) , both in upper respiratory specimens. Initial and peak mean viral loads of 6.17 and 6.91 log 10 copies/mL, respectively, have also been reported for 10 SARS-CoV-2 infected patients severe disease; J o u r n a l P r e -p r o o f values were 10-fold lower (initial viral load) and 30-fold lower (peak viral load) in 13 patients with mild disease by . Viral loads in respiratory samples from patients infected with other respiratory coronaviruses have also been reported. In 14 patients infected with SARS-CoV-1, peak viral loads of approx. 5.5 to 8.5 log 10 /mL were documented in nasopharyngeal aspirates (Peiris et al., 2003) . For patients with severe MERS, peak viral loads in sputum or tracheal aspirates ranged from 6 -9 log 10 copies/mL while mild cases were at least 100-fold lower (Oh et al., 2016) . Viral load results for common respiratory coronaviruses such as strains NL63 and OC43 are generally 1,000-to 10,000-fold lower compared to peak values for SARS-CoV-1, SARS-CoV-2 and MERS (Lassaunière et al., 2010) .

The limitations of this study are that clinical information was not available from the reference laboratory caseload and full de-identification of samples was required for research use. Most importantly, the proportion of samples tested from symptomatic patients versus asymptomatic individuals was not known, nor is it known when samples were collected relative to the time of symptom onset for those patients suffering from disease. Therefore the overall prevalence of positivity is minimally significant and the prevalence by birth year may well be skewed based on likelihood of sampling due to age or occupation. However, additional study of asymptomatic or symptomatic patient samples with defined clinical characteristics is warranted based on our data.

In summary, our results demonstrate that a significant number of patients have extremely high levels of virus (> 8 log 10 copies/mL) in respiratory samples and thus may be responsible for a disproportionate level of transmission to contacts and contamination of environmental surfaces. Additionally, results demonstrated that samples with low viral loads (<1,000 copies/mL) are common, and individuals from which these samples were collected may represent a low risk for transmission. This study supports the J o u r n a l P r e -p r o o f concept that quantitative viral detection methods for SARS-CoV-2 diagnosis may provide significant benefits in efforts to control viral transmission, and perhaps even in the medical care of these patients.

The authors have no conflicts of interest to declare. 

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea

A novel multiplex real-time RT-PCR assay with FRET hybridization probes for the detection and quantitation of 13 respiratory viruses

Viral Load Kinetics of MERS Coronavirus Infection

Viral load of SARS CoV-2 in clinical samples

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

A.

Log 10 copies/mL No. of Positive Samples